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Distal vein patch with an arteriovenous fistula: A
viable option for the patient without autogenous
conduit and severe distal occlusive disease
Richard F. Neville, MD,a Benzon Dy, BS,b Niten Singh, MD,c and Kent J. DeZee, MD, MPH,d Washington,
DC; and Tacoma, Wash
Background: The addition of a distal arteriovenous fistula (DAVF) to improve patency in lower extremity bypass is well
described. This report describes a technique of using a distal AVF to enhance a distal vein patch (DVP) in patients without
adequate autogenous conduit and who have concomitant severely disadvantaged arterial runoff.
Methods: A retrospective review fromMay 2002 to May 2007 analyzed 270 tibial bypasses. DVP-AVF was the conduit in
30 bypass grafts. Patient demographics included 16 men, 14 women, diabetes mellitus (67%), and chronic renal failure
(20%). All patients had limb-threatening ischemia manifest as rest pain or tissue loss, with 20 patients referred after failed
prior revascularization: 11 failed bypasses, and nine failed endovascular interventions. In each case, the only outflow
artery available was an isolated tibial segment or a diseased pedal vessel not ordinarily deemed suitable for bypass. At
surgery, a common ostium AVF was created between the outflow tibial artery and corresponding tibial vein before DVP
construction. Follow-up was 1 to 24months, with graft function evaluated by pulse examination and duplex surveillance.
Primary patency and limb salvage  SE were determined by life-table analysis using Rutherford criteria.
Results:The proximal anastomosis originated from the external iliac (23%), common femoral artery (43%), and superficial
femoral artery (33%). Outflow arteries included the anterior tibial (40%), posterior tibial (30%), and peroneal (30%).
Venous hypertension in the bypassed limb was noted, but not considered problematic in any patient. Perioperative graft
failure occurred in one patient. Six graft failures led to six major amputations (1 above knee; 5 below knee). One patent
graft was excised due to infection. Primary patency at 6, 12, 18, and 24 months was 78.3%  6.8%, 78.3%  10.5%,
62.6%  11.1%, and 62.6% 15.6%; limb salvage was 78.7% 6.7%, 78.7% 10.1%, 78.7%  10.1%, and 57.7% 12.5%.
Conclusion: This early experience describes a modification of the DVP technique in patients with threatened limb loss and
severely disadvantaged tibial runoff. The addition of an AVF may reduce outflow resistance, thereby contributing to
higher flow rates and improved graft patency. Further investigation is warranted because the DVP-AVF technique may
result in acceptable graft patency and limb salvage for patients with no other alternative than amputation. (J Vasc Surg
2009;50:83-8.)Despite the development of endovascular techniques,
tibial artery bypass remains an important option for revas-
cularization of the threatened limb. However, distal bypass
is often relegated to those patients with severe, long seg-
ment tibial disease not deemed suitable for an endovascular
approach. Although it is recognized that prosthetic grafts
have been used with uniformly poor results for tibial bypass,
other conduits such as arm vein or spliced autologous vein
may be of inadequate length or quality, especially in reop-
erative situations.1,2
We have previously reported the use of a distal vein
patch (DVP) to enhance the performance of polytetrafluo-
roethylene (PTFE) as a conduit for tibial revascularization
in those patients lacking adequate autogenous conduit.3,4
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doi:10.1016/j.jvs.2008.12.052A subset of these patients presented with concomitant
severely compromised arterial outflow for revasculariza-
tion. Other authors have reported success for difficult tibial
artery bypass with the use of a distal arteriovenous fistula
(AVF).5-9 We extrapolated from this experience to opti-
mize bypass patency in those patients lacking autogenous
conduit and disadvantaged arterial runoff by combining the
DVP technique with a common ostium AVF.
METHODS
The Institutional Review Board approved a retrospec-
tive medical records review that was performed from the
date of the first DVP/AVF bypass (May 2002 to May
2007). During this 5-year interval, 270 tibial artery bypass
procedures were performed, including 95 in which a DVP
was used as the conduit. A common ostium distal AVF was
incorporated with the technique in 30 of these DVP pro-
cedures, representing 11.1% of all tibial revascularizations
performed during the study period. A retrospective review
of these 30 patients assessed graft patency and limb salvage.
Patient medical records were reviewed from the office and
vascular laboratory, and clinical status was updated by
direct contact with the patient or family as of July 2007.
All patients were evaluated preoperatively with vascular
laboratory studies and contrast arteriography to plan the
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tients had adequate autologous venous conduit for bypass
due to prior harvesting for cardiac or vascular procedures,
or venous stripping. The lack of vein was confirmed by
physical examination and evaluation with duplex ultra-
sound (DUS) imaging. In all 30 patients, the target artery
for distal revascularization was an isolated paramalleolar
tibial segment or small diseased pedal artery (Fig 1). How-
ever, there was no prospective definition of “poor runoff”
or scoring of arterial segments for any of these patients.
Distal bypass was performed under general or epidural
anesthesia as determined by the patient’s medical condition
and the opinion of the anesthesia team. The inflow artery
was exposed in the standard fashion, and distal exposure
varied according to the tibial artery chosen for the proce-
dure. After exposure of the tibial artery and corresponding
tibial veins, a 2- to 4-cm autogenous patch was harvested
from ipsilateral or contralateral venous remnants, femoral
vein, or endarterectomized segments of thrombosed super-
ficial femoral artery (SFA). The patch configuration re-
quires less material than other reported cuffs.
We used endarterectomized SFA in four DVP patients
instead of arm vein or small saphenous vein to avoid the
additional incisions and dissection in the arm or posterior
calf. The occluded SFAwas available through the dissection
already performed for the inflow anastomosis. In none of
Fig 1. A, Arteriogram shows an isolated peroneal seg
B, Arteriogram from another patient shows an isolatethe AVF patients was a concomitant endarterectomizedSFA used as the patch. The autogenous tissue remnants
were irrigated with prepared vein solution composed of
buffered saline solution (Plasma-Lyte-A; Cardinal Health,
Dublin, Ohio; 1000 mL, pH 7.4), heparin (5000 U),
calcium chloride 10% (100 mg), and papaverine (120 mg).
An externally reinforced, 6-mm, thin-walled stretch
PTFE graft was tunneled between the proximal and distal
arterial dissections. Systemic heparinization was performed
before arterial clamp placement. An end-to-side proximal
anastomosis was performed using two Prolene sutures
(Ethicon, Somerville, NJ) and a “parachute” technique to
secure the heel and toe of the anastomosis. The proximal
PTFE graft was controlled with a soft-jawed clamp, and
flow was re-established through the native circulation by
clamp removal from the inflow artery.
The distal anastomosis was then addressed. First, a
common ostium AVF was created between the recipient
tibial artery and corresponding tibial vein. Both vessels
were controlled, and a longitudinal arteriotomy and corre-
sponding venotomy was performed. The central medial
walls of the artery and vein were sewn together with a 7-0
Prolene suture in a continuous fashion, everting the edges
so that the suture material did not impinge into the lumen,
with knots secured outside the lumen (Fig 2). The previ-
ously harvested autogenous patch was then sewn in place by
performing patch angioplasty over the common ostium
t as the only option for distal revascularization.
terior tibial segment.menusing 7-0 Prolene suture (Fig 3). The PTFE was anasto-
JOURNAL OF VASCULAR SURGERY
Volume 50, Number 1 Neville et al 85mosed to the common ostium patch using a 6-0 Prolene
suture with the “parachute” configuration, as previously
described for the DVP bypass3 (Fig 4). Completion arte-
riography was performed in each case.
Patients were transferred to the intensive care or step-
down unit based on their medical condition. A heparin
infusion was started 4 to 6 hours postoperatively, and oral
anticoagulation with warfarin was started on postoperative
day 1. Patients were continued on long-term anticoagula-
tion to maintain an international normalized ratio of 2.0 as
a goal.
Patients were evaluated in the office 10 to 14 days
postoperatively with a pulse evaluation and hand held
Doppler interrogation. Formal graft surveillance was per-
formed with DUS imaging at 3, 6, 12, and 18months, and,
then annually. Postoperative DUS assessment was per-
formed according to the routine for graft surveillance. Graft
patency was the major concern, but venous flow in the
fistula can also be appreciated during insonation of the
distal anastomosis, although this is not part of the surveil-
lance protocol. Arteriography or magnetic resonance an-
giography was performed if any problem was indicated by
the surveillance DUS examination. Amputations or other
morbidity were noted. Primary patency and limb salvage
were reported by life-table and Kaplan-Meier analysis using
Fig 2. Schematic drawing shows distal arteriovenous fistula con-
struction. A, Vascular control of paired tibial artery (A) and vein
(V). B,Common ostium fistula with suture line joining the central
walls of the two vessels.
Fig 3. Schematic drawing shows the distal vein patch (DVP) over
the common ostium arteriovenous fistula.the Rutherford criteria.RESULTS
The 30 patients in the study cohort were a mean age of
73.5 years and comprised 16 men (54%) and 14 women
(46%). Six patients (20%) had dialysis-dependent renal fail-
ure, and 20 (67%) had diabetes mellitus. All 30 patients had
critical limb ischemia as an indication for intervention,
manifest as rest pain or tissue loss, or both; three (10%) had
rest pain, and 27 (90%) had tissue loss. All patients were
considering primary amputation if additional revasculariza-
tion was not possible.
The referral for 20 patients (67%) occurred after previ-
ous attempts at revascularization had failed; 11 presented
with a prior failed bypass, and nine after a failed catheter-
based intervention. The proximal anastomosis originated at
the common femoral artery (CFA) in 13 (43.3%), the SFA
in 10 (33.3%), or external iliac artery in seven (23.3%).
Recipient arteries included the anterior tibial in 12 (40%),
posterior tibial in nine (30%), or peroneal in nine (30%). In
each case, this recipient artery was an isolated paramalleolar
tibial segment or a diseased pedal vessel not deemed opti-
mal for bypass as assessed by preoperative angiography. A
mild tomoderate degree of postoperative venous hyperten-
sion due to the AVF in the bypassed limb was routinely
noted. No AVFs were ligated due to edema. The edema
resolved with time in most patients and was not considered
problematic. If edema persisted 3 months, patients were
prescribed a light compression stocking.
Follow-up ranged from 1 to 48 months, with patency
and limb salvage data assessed at 6-month intervals to 24
months (Table). Perioperative graft failure occurred in one
patient, with one patent graft excised 3 months due to
infection. Five late graft failures occurred in follow-up, and
in all, the AVFwas occluded at the time of failure. Owing to
the severity of distal disease, these patients chose to proceed
with amputation at the time of graft failure. The AVF did
not affect the level of amputation or hasten the need for
amputation. The AVFs were patent at the time of the
original bypass (intraoperative arteriogram or intraopera-
tive US scan) and were all thrombosed at the time of graft
failure. This resulted in six major amputations (1 above
Fig 4. Schematic drawing of the polytetrafluoroethylene (PTFE)
bypass with a distal vein patch and arteriovenous fistula at comple-
tion. A, Artery; V, vein.knee, 5 below knee) and a 78% primary patency by life-table
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patients (Fig 5).
During the period of analysis, three patients had patent
bypass grafts 2 years, with the longest patency interval
being 42months. Limb salvage rates were 78% at 1 year and
57% at 2 years (Fig 6). The limb salvage rate was less than
patency to a degree that reflects our previous series. If the
graft remains patent, then the limb team can usually man-
age the soft tissue to save the limb. This is a strong argu-
ment to the team approach to limb salvage.
DISCUSSION
Patients in need of distal bypass who lack both adequate
autogenous conduit and a good target artery for bypass are
a small but challenging group. Our total DVP experience
now numbers 300 patients, this series examines our re-
sults in this subset of our DVP experience in which an AVF
was added to the distal anastomosis in an effort to improve
graft performance in the face of disadvantaged arterial
runoff. In our experience, precuffed or “hooded” PTFE
grafts led to early graft failure, and our experience with
CryoVein (CryoLife Inc, Kennesaw, Ga) has been equally
Table. Primary patency and limb salvage rates at
6-month intervals
Interval
Primary patency Limb salvage
No. Percentage No. Percentage
6 mon 29 78.3  6.8 29 78.7  6.7
12 mon 12 78.3  10.5 13 78.7  10.1
18 mon 12 62.6  11.1 13 78.7  10.1
24 mon 6 62.6  15.6 9 57.7  12.5
24 mon 3 4
Fig 5. Primary patency for distal vein patch bypass with arterio-
venous fistula.poor.This suboptimal experience led to the search for a
better option and development of the DVP bypass tech-
nique. Our experience with arm vein has been good, but
given the success of the DVP technique, we reserve the use
of arm vein for younger, good-risk patients without renal
failure who have upper extremity dialysis access require-
ments. Therefore, the additional 65 patients without au-
togenous vein during the contemporaneous time period
underwent a standard DVP bypass. The fistula group com-
prised a small cohort during this time, and surgeon judg-
ment about the severity of distal disease for bypass was a key
factor in the use of a concomitant AVF. The extent of distal
disease precluded consideration of endovascular therapy in
this patient cohort.
AVFs have been hypothesized to benefit lower extrem-
ity revascularization in two ways. Before the advent of
direct arterial bypass, fistulas were constructed to create
flow reversal in the venous circulation and carry arterial
blood to the capillary bed in a retrograde fashion.10,11With
the advance of standard bypass techniques, direct revascu-
larization of the arterial tree became a more effective
method than retrograde venous flow reversal to alleviate
ischemia in the lower extremity. AVFs were then proposed
as a method to decrease outflow resistance and improve
prosthetic graft performance.12,13 The venous circulation
accepts much of the flow overload in the high resistance
arterial circuit, thereby increasing graft flow above the
critical thrombotic threshold in a disadvantaged runoff
situation.14 Although construction of an AVF does increase
graft flow, it has been difficult to demonstrate that this leads
to improvement in graft patency.15 Adding an AVF to the
DVP configuration may decrease outflow resistance and
improve graft hemodynamics. Although this does not di-
rectly correlate with a reduction in the formation of intimal
hyperplasia, it may improve graft performance from a he-
Fig 6. Limb salvage for patients with bypass using distal vein
patch with arteriovenous fistula.modynamic approach.
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struction of an AVF to improve distal bypass graft perfor-
mance. In 1980, Ibrahim and Dardik5 reported the use of a
common ostium fistula between the tibial artery and vein
before anastomosis with a human umbilical vein graft.5 The
authors updated their experience in 1991, reporting 210
tibial bypasses with adjunct fistulas.14 The results improved
during a 10-year period, with 44% patency in the final
group from 1983 to 1986. In this group, fistulas were used
with both prosthetic and autogenous grafts. The authors
noted an increase in mean graft velocity and flow volume,
with no instances of proximal arterial steal by arteriography
and DUS. If the fistulas remained patent, graft patency was
58% at 2 years compared with 25% graft patency without
fistulas.
Ascer et al9 described an AVF created by distal ligation
of a tibial vein with subsequent anastomosis of the proximal
venous segment to the corresponding tibial artery. A pros-
thetic graft was then sutured to the anterior surface of the
venous hood, “piggybacking” the graft onto the AVF at the
anastomosis. Banding of the proximal tibial vein was per-
formed in 38% of these bypasses. The cumulative 3-year
patency was 62%, with 77% limb salvage.9
Poor tibial runoff has prompted other groups to add an
adjuvant AVF remote from the actual distal anastomosis. In
this configuration, the fistula was added to improve graft
performance to disadvantaged tibial arteries for infrapopli-
teal bypass using PTFE.7 Paty et al7 describe a fistula
constructed 5 to 15 cm distal to the anastomosis in an
attempt to increase flow not only in the graft but also in the
artery between the anastomosis and the fistula. At 1 year the
patency was 67% in 16 patients. However, although in-
creased flow velocity was noted in the graft (264 mL/min)
and the fistula (170 mL/min), flow was decreased in the
distal artery (19 mL/min). This technique requires addi-
tional tibial vessel dissection remote from the anastomosis
and may not be possible due to length restrictions in the
distal third of the leg.
In a later publication, the authors compared PTFE
bypasses with a distal vein cuff to bypasses using the remote
AVF. Primary patency and limb salvage rates were 76% and
92% for the distal vein cuff group, and 48% and 76% for the
fistula group, respectively.16 In the grafts that failed, the
authors noted that the distal vein cuff remained patent,
allowing for simpler graft revision compared with the grafts
with a remote fistula that were totally occluded at failure.
Our DVP experience confirms this observation. Al-
though the prosthetic graft may occlude, the vein patch
area of the anastomosis remains patent after graft thrombosis,
allowing for easier thrombectomy with re-establishment
of secondary patency. In our series, if the DVP-AVF bypass
failed, then amputation was performed because the severe
distal disease precluded hope for durable secondary pa-
tency.
Ducasse et al17 also assessed the usefulness of a fistula in
bypasses using PTFE with a vein cuff. Primary patency was
68%, 53%, and 44% at 1, 2, and 3 years, respectively.17These authors concluded that the fistula allowed patientswith poor runoff to achieve comparable, but not improved,
results compared with direct PTFE bypass. Laurila et al18
compared infrapopliteal vein bypass with vein grafts to
“poor-outflow arteries.” Although the fistula did not im-
prove results, they did note that an adjunct fistula allowed
patients with poor runoff to achieve comparable results for
infrapopliteal bypass with superior runoff.18 Graft flow was
significantly higher in the fistula group.
In our series, a common ostium fistula similar to the
Dardik configuration was combined with the DVP tech-
nique. The DVP technique lends itself to this type of
common ostium adjunctive fistula. There is minimal addi-
tional dissection required of the corresponding tibial vein,
and suturing the common medial walls of the artery and
vein adds only 10 to 15 minutes to the procedure. Inter-
position of the autogenous vein patch over the entire
common ostium configuration was performed before the
PTFE anastomosis. This configuration resulted in a com-
plete autogenous tissue interface with the tibial artery
around the entire anastomosis. This is beneficial in two
ways: technical ease of the anastomosis, and a theoretic
advantage for minimizing the formation of anastomotic
hyperplasia.
We have previously theorized that the benefits of a
DVP for prosthetic bypass may include factors that improve
graft hemodynamics or create a biologic “buffer zone” at
the anastomosis, or both.19-23 However, these anastomotic
factors do not address outflow resistance or resulting graft
flow velocity and flow volume. These obviously important
factors for graft performance may reach critical importance
with severely disadvantaged arterial runoff. The construc-
tion of an AVF at the distal anastomosis may affect these
factors through several mechanisms. The AV communica-
tion involves reduction of outflow resistance. This en-
hanced outflow may also sustain a threshold level of graft
flow needed to maintain patency. It remains difficult to
prove any definite advantage for addition of an AVF at the
distal anastomosis in the subset of patients with severe distal
occlusive disease and no autogenous conduit for bypass. A
comparison of patency rates between this small cohort and
our original DVP experience3 indicates that the addition of
an AVF may allow comparable patency to be reached at 1
year in these patients with poor distal targets for bypass.
This adjunctive technique adds little in terms of operative
time and in this initial experience demonstrates reasonable
outcomes in a patient population otherwise facing amputa-
tion. It may be considered if an aggressive attempt at limb
salvage is warranted.
CONCLUSIONS
An aggressive approach to limb salvage will continue to
require the use of distal bypass in certain patients, even in
the era of endovascular therapy. As in other vascular beds,
lower extremity bypass will become increasingly challeng-
ing as catheter-based therapies evolve. Surgical bypass will
be required in the setting of severe distal occlusive disease
without available autogenous conduit. Although it is diffi-
cult to prove a definite benefit without randomized data,
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that are dedicated to limb salvage in these challenging
patients.
In this early experience we describe acceptable early
patency and limb salvage in a technique that combines a
DVP with an AVF. The procedure does not increase pa-
tency compared with our other DVP patients. However,
addition of the AVF does result in similar patency and limb
salvage in a group of patients in whom that was not to be
expected. This patient group was to be offered primary
amputation due to the poor distal arterial anatomy in
consideration of bypass. Construction of the AVF does not
increase operating time to any meaningful degree because
the exposure and vascular control is the same with or
without the AVF. Further investigation is warranted with
increased numbers and longer follow-up to confirm that
the technique is a useful addition to the armamentarium of
options for those patients with disadvantaged runoff and no
autogenous conduit.
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